Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study
- PMID: 23721377
- PMCID: PMC3679727
- DOI: 10.1186/1471-2334-13-252
Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study
Abstract
Background: Skin and soft tissue infections (SSTIs) are commonly occurring infections with wide-ranging clinical manifestations, from mild to life-threatening. There are few population-based studies of SSTIs in the period after the rapid increase in community-acquired methicillin-resistant Staphyloccus aureus (MRSA).
Methods: We used electronic databases to describe the incidence, microbiology, and patient characteristics of clinically-diagnosed skin and soft tissue infections (SSTIs) among members of a Northern California integrated health plan. We identified demographic risk factors associated with SSTIs and MRSA infection.
Results: During the three-year study period from 2009 to 2011, 376,262 individuals experienced 471,550 SSTI episodes, of which 23% were cultured. Among cultured episodes, 54% were pathogen-positive. Staphylococcus aureus (S. aureus) was isolated in 81% of pathogen-positive specimens, of which nearly half (46%) were MRSA. The rate of clinically-diagnosed SSTIs in this population was 496 per 10,000 person-years. After adjusting for age group, gender, race/ethnicity and diabetes, Asians and Hispanics were at reduced risk of SSTIs compared to whites, while diabetics were at substantially higher risk compared to non-diabetics. There were strong age group by race/ethnicity interactions, with African Americans aged 18 to <50 years being disproportionately at risk for SSTIs compared to persons in that age group belonging to other race/ethnicity groups. Compared to Whites, S. aureus isolates of African-Americans and Hispanics were more likely to be MRSA (Odds Ratio (OR): 1.79, Confidence Interval (CI): 1.67 to 1.92, and, OR: 1.24, CI: 1.18 to 1.31, respectively), while isolates from Asians were less likely to be MRSA (OR: 0.73, CI: 0.68 to 0.78).
Conclusions: SSTIs represent a significant burden to the health care system. The majority of culture-positive SSTIs were caused by S. aureus, and almost half of the S. aureus SSTIs were methicillin-resistant. The reasons for African-Americans having a higher likelihood, and Asians a lower likelihood, for their S. aureus isolates to be methicillin-resistant, should be further investigated.
Similar articles
-
Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus.Diagn Microbiol Infect Dis. 2013 May;76(1):24-30. doi: 10.1016/j.diagmicrobio.2013.02.020. Epub 2013 Mar 26. Diagn Microbiol Infect Dis. 2013. PMID: 23537783
-
Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.J Infect Public Health. 2013 Dec;6(6):423-30. doi: 10.1016/j.jiph.2013.04.010. Epub 2013 Jun 15. J Infect Public Health. 2013. PMID: 23999333
-
Is methicillin-resistant Staphylococcus aureus involved in community acquired skin and soft tissue infections? Experience from a tertiary care centre in Mumbai.J Postgrad Med. 2012 Jan-Mar;58(1):3-7. doi: 10.4103/0022-3859.93245. J Postgrad Med. 2012. PMID: 22387641
-
Community-genotype methicillin-resistant Staphylococcus aureus skin and soft tissue infections in Latin America: a systematic review.Braz J Infect Dis. 2021 Jan-Feb;25(1):101539. doi: 10.1016/j.bjid.2021.101539. Epub 2021 Feb 16. Braz J Infect Dis. 2021. PMID: 33607082 Free PMC article.
-
Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections.Curr Opin Infect Dis. 2003 Apr;16(2):103-24. doi: 10.1097/00001432-200304000-00007. Curr Opin Infect Dis. 2003. PMID: 12734443 Review.
Cited by
-
Green Algae as a Drug Delivery System for the Controlled Release of Antibiotics.Chemistry. 2020 Dec 15;26(70):16644-16648. doi: 10.1002/chem.202003821. Epub 2020 Nov 18. Chemistry. 2020. PMID: 32910832 Free PMC article.
-
Prevention Strategies for Recurrent Community-Associated Staphylococcus aureus Skin and Soft Tissue Infections.Curr Infect Dis Rep. 2019 Mar 11;21(4):12. doi: 10.1007/s11908-019-0670-0. Curr Infect Dis Rep. 2019. PMID: 30859379 Review.
-
The ever-changing microenvironment of Staphylococcus aureus in cutaneous infections.Animal Model Exp Med. 2024 Oct;7(5):707-716. doi: 10.1002/ame2.12413. Epub 2024 May 2. Animal Model Exp Med. 2024. PMID: 38695685 Free PMC article.
-
Harnessing the Dual Antimicrobial Mechanism of Action with Fe(8-Hydroxyquinoline)3 to Develop a Topical Ointment for Mupirocin-Resistant MRSA Infections.Antibiotics (Basel). 2023 May 10;12(5):886. doi: 10.3390/antibiotics12050886. Antibiotics (Basel). 2023. PMID: 37237789 Free PMC article.
-
Antibiotic prescribing for skin infections: broader coverage in emergency settings and differences by race.Arch Dermatol Res. 2024 Dec 7;317(1):80. doi: 10.1007/s00403-024-03604-x. Arch Dermatol Res. 2024. PMID: 39644410 No abstract available.
References
-
- Dryden M. Complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: epidemiology, risk factors, and presentation. Surg Infect (Larchmt) 2008;9(Suppl 1):s3-10. - PubMed
-
- Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003;52(Suppl 1):i3–i17. - PubMed
-
- Dryden MS. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents. 2009;34(Suppl 1):S2–S7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources